Profiel
Ernest Loumaye was the founder of PregLem SA, founded in 2006, and served as Chief Executive Officer from 2011 to 2012.
Dr. Loumaye was the founder of ObsEva SA, founded in 2012, and served as Chairman from 2023 to 2024.
Former jobs include Chairman at Calliditas Therapeutics Suisse SA from 2011 to 2016, Director at Ava AG from 2019 to 2021, Vice President-Medical Sciences at Ipsen SA, and Head-Clinical Development at Serono SA. Education includes undergraduate and doctorate degrees from Université Catholique de Louvain.
Eerdere bekende functies van Ernest Loumaye
| Bedrijven | Functie | Einde |
|---|---|---|
| OBSEVA SA | Algemeen Directeur | 01-12-2020 |
Ava AG
Ava AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets wearable medical devices for women's health & fertility monitoring through online | Directeur/Bestuurslid | 01-01-2021 |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Voorzitter | 01-01-2016 |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Algemeen Directeur | 01-10-2012 |
| IPSEN | Corporate Officer/Principal | - |
Opleiding van Ernest Loumaye
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Health Technology |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ObsEva SA
ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Ava AG
Ava AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets wearable medical devices for women's health & fertility monitoring through online | Electronic Technology |
















